Korean J Med.
2006 Sep;71(3):241-243.
The relationship and clinical utility of serum levels of soluble receptor activator of nuclear factors B ligand (sRANKL) and osteoporosis in patients with ankylosing spondylitis
- Affiliations
-
- 1Department of Internal Medicine, Hospital for Rheumatic Diseases College of Medicine, Hanyang University, Seoul, Korea.
Abstract
- No abstract available.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Development of osteoporosis and the imbalance of RANKL/OPG in ankylosing spondylitis
- Salivary soluble receptor activator of nuclear factor kappa B ligand/osteoprotegerin ratio in periodontal disease and health
- The Relationship between Wnt Antagonist Genes Polymorphisms and Changes in Production of Osteoprotegerin and Soluble Receptor Activator of NF-kB by Whole Blood Cells after Hormone Therapy
- The Relationship between Polymorphisms of Wnt Antagonists Genes and Production of Osteoprotegerin (OPG)-soluble receptor Activator of NF-kappaB Ligand (sRANKL) by Whole Blood Cells
- The Association between Single Nucleotide Polymorphisms of Sclerostin (SOST) Gene, Bone Mineral Density and Circulating Osteoprotegerin (OPG) - Soluble Receptor Activator of NF-kappaB Ligand (sRANKL) in Postmenopausal Korean Women
